HPTN Publications

Schlusser KE, Konikoff J, Kirkpatrick AR, Morrison C, Chipato T, Chen PL, Munjoma M, Eshleman SH, Laeyendecker O . Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence. AIDS Res Hum Retroviruses. 2017, 33: 555-557
Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O . Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma. PLoS One. 2017, 12: e0172283
Schlusser KE, Sharma S, de la Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, German D, Laeyendecker O, INSIGHT START Study Group . Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial. AIDS Behav. 2018, 22: 2277-2283
Schreiber CA, Sammel M, Hillier SL, Barnhart KT . A Little Bit Pregnant: Modeling How the Accurate Detection of Pregnancy Can Improve HIV Prevention Trials. Am J Epidemiol. 2009, 169: 515-21 PMCID: 2732971
Schreiber CA, Whittington S, Cen L, Maslankowski L . Good intentions: risk factors for unintended pregnancies in the US cohort of a microbicide trial. Contraception. 2011, 83: 74-81 PMID:21134507
Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP . Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol. 2001, 153: 619-27
Seeley J, Bond V, Yang B, Floyd S, MacLeod D, Viljoen L, Phiri M, Simuyaba M, Hoddinott G, Shanaube K, Bwalya C, de Villiers L, Jennings K, Mwanza M, Schaap A, Dunbar R, Sabapathy K, Ayles H, Bock P, Hayes R, Fidler S, for the HPTN 071 Study Team . Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa. AIDS Behav. 2019, 23: 929-946
Shaboltas AV, Toussova OV, Hoffman IF, Heimer R, Verevochkin SV, Ryder RW, Khoshnood K, Perdue T, Masse BR, Kozlov AP . HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. JAIDS. 2006, 41: 657-63 PMID: 16652041
Shafer RW, Chaung T, Hsu P, White CB, Katzenstein DA . Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. AIDS Res Hum Retroviruses. 1999, 15: 65-9
Shanaube K, Schaap A, Chaila MJ, Floyd S, Mackworth-Young C, Hoddinott G, Hayes R, Fidler S, Ayles H, HPTN 071 Study Team . Community intervention improves knowledge of HIV status of adolescents in Zambia: findings from HPTN 071-PopART for youth study. AIDS. 2017, 31 Suppl 3: S221-S232
Shanaube K, Schaap A, Floyd S, Phiri M, Griffith S, Chaila MJ, Peter Bock, Hayes R, Fidler S, Ayles H, on behalf of the HPTN 071 (PopART) Study Team . What Works-Reaching Universal HIV testing: Lessons from HPTN 071 (PopART) trial in Zambia. AIDS. 2017, 31: 1555-1564
Shava E, Lipira LE, Beauchamp GG, Donnell DJ, Lockman S, Ruan Y, Shao Y . Risky Sexual Behavior Among Individuals Receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058. J Acquir Immune Defic Syndr. 2018, 78: 300-307
Sheehan DM, Miller RP, Trepka MJ, Smith LR, Latkin C . Role of Social Network Sexual Norms and Behaviors on the HIV Sexual Risk Behaviors of People Who Inject Drugs in HPTN 037. AIDS Behav. 2019, 23: 1604-1611
Shelus V, Taylor J, Greene E, Stanton J, Pack A, Tolley EE, Branson BM, El-Sadr WM, Pollydore J, Gamble T . It's all in the timing: Acceptability of a financial incentive intervention for linkage to HIV care in the HPTN 065 (TLC-Plus) study. PLoS One. 2018, 13: e0191638
Sheppard HW, Celum CL, Michael NL, O'Brien S, Dean M, Carrington M, Dondero D, Buchbinder SP . HIV-1 infection in individuals with the CCR5-delta32/delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr. 2002, 29: 307-13
Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, Bassett MT . Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months. J Acquir Immune Defic Syndr. 2003, 34: 482-90
Shoptaw S, Montgomery B, Williams CT, El-Bassel N, Aramrattana A, Metsch L, Metzger DS, Kuo I, Bastos FI, Strathdee SA . Not just the needle: the state of HIV-prevention science among substance users and future directions. J Acquir Immune Defic Syndr. 2012, 63: S174-8 PMCID: 3739052
Silverthorn CF, Parsons TL . A validated new method for nevirapine quantitation in human plasma via high-performance liquid chromatography. Biomed Chromatogr. 2006, 20: 23-7 PMID: 15920701
Simwinga M, Bond V, Makola N, Hoddinott G, Belemu S, White R, Shanaube K, Seeley J, Moore A, HPTN 071 Study Team . Implementing Community Engagement for Combination Prevention: Lessons Learnt From the First Year of the HPTN 071 (PopART) Community-Randomized Study. Curr HIV/AIDS Rep. 2016, 13: 194-201
Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JSA . Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV. Lancet. 2001, 358: 1611-12
Sista ND, Abdool Karim Q, Hinson K, Donnell D, Eshleman SH, Vermund SH . Experience in international clinical research: the HIV Prevention Trials Network. Clin Invest. 2011, 1: 1609-18
Sithole B, Mbhele L, Van Rooyen H, Khumalo-Sakutukwa G, Richter L . Only skin deep: limitations of public health understanding of male circumcision in South Africa. S Afr Med J. 2009, 99: 647 PMCID: 2861782
Sivay MA, Zhang Y, Hudelson SE, Li M, Piwowar-Manning E, Marzinke MA, Bokoch K, Grant RM, Eshleman SH, Amico RK, Redd A, Hendrix CW, Anderson PL, Bekker LG, van Griensven F, Mannheimer S, Hughes JP, Grant R, HPTN 067/ADAPT Study Team . Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT. J Acquir Immune Defic Syndr. 2017, 75: 271-279
Sivay MV, Fogel JM, Wang J, Zhang Y, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Hamilton EL, Kahn K, Selin A, Gomez-Olive FX, MacPhail C, Hughes JP, Pettifor A, Eshleman SH . Natural control of HIV infection in young women in South Africa: HPTN 068. HIV Clin Trials. 2018, 19: 202-208
Sivay MV, Hudelson SE, Wang J, Agyei Y, Hamilton EL, Selin A, Dennis A, Kahn K, Gomez-Olive FX, MacPhail C, Hughes JP, Pettifor A, Eshleman SH, Grabowski MK . HIV-1 diversity among young women in rural South Africa: HPTN 068. PLoS One. 2018, 13: e0198999
Smita J, Soma D, Beverly B, Albert P, JoAnn K, Fang G, Missy C, Lydia ST, Anjali P, Arun R, Sanjay M, Steven J R; HIV Prevention Trial Network HPTN 047 Protocol Team . Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India. AIDS Res Ther (Epub). 2006, 3: 4 PMCID: 1435917
Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS . The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr. 2013, 63: S187-99
Smith, L. R., Strathdee, S. A., Metzger, D., Latkin, C. . Evaluating network-level predictors of behavior change among injection networks enrolled in the HPTN 037 randomized controlled trial. Drug Alcohol Depend. 2017, 175: 164-170
Solomon S, Buck J, Chaguturu SK, Ganesh AK, Kumarasamy N . Stopping HIV before it begins: issues faced by women in India. Nat Immunol. 2003, 4: 719-21
Solomon SS, Solomon S, Masse BR, Srikrishnan AK, Beauchamp G, Thamburaj E, Gulvady M, Anand S, Mayer KH . Risk reduction counseling is associated with decreased HIV transmission-associated behaviors in high-risk Indian heterosexuals. J Acquir Immune Defic Syndr. 2006, 42: 478-83 PMID: 16763526
Spielberg F, Critchlow C, Vittinghoff E, Coletti AS, Sheppard H, Mayer KH, Metzgerg D, Judson FN, Buchbinder S, Chesney M, Gross M . Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS. 2000, 14: 1819-28
Spielberg F, Critchlow C, Vittinghoff E, Gross M, Doherty-Iddings P, Scotti R, Judson FN, Marmor M, Buchbinder S . Slow diffusion of home HIV-specimen collection: provider concerns at odds with client preferences. Sex Transm Dis. 2001, 28: 51-7
Srikrishnan AK, Hendriksen E, Vallabhaneni S, Johnson SL, Raminani S, Kumarasamy N, Hobsen J, Solomon S, Mayer KH, Safren SA . Sexual behaviors of individuals with HIV living in South India: a qualitative study. AIDS Educ Prev. 2007, 19: 334-45
Srikrishnan AK, Venkatesh K, Solomon S, Thamburaj E, Anand S, Kosalaraman KG, Balakrishnan P, Mayer K . Expansion of HIV Laboratory Diagnostic Services in Chennai, India 2001-2006: Is the Growth Commensurate with the Need?. PLoS One. 2008, 3: e3471 PMCID:2565796
Stephenson J . Health agencies update: HIV Prevention Trials Network. JAMA. 2000, 284: 822
Stone E, Heagerty P, Vittinghoff E, Douglas JM, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR, Buchbinder SP, Douglas JM Jr, Seage GR 3rd . Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol. 1999, 20: 495-501
Stoner MCD, Dennis AM, Hughes JP, Eshleman SH, Sivay MV, Hudelson SE, Grabowski KM, Gomez-Olive FX, MacPhail C, Piwowar-Manning E, Kahn K, Pettifor A . Characteristics associated with HIV transmission networks involving adolescent girls and young women in HIV Prevention Trials Network (HPTN) 068 study. Sexually Transmitted Diseases.
Stoner MCD, Edwards JK, Miller WC, Aiello AE, Halpern CT, Julien A, Ruckinski KB, Selin A, Twine R, Hughes JP, Wang J, Agyei Y, Gomez-Olive FX, Wagner RG, Laeyendecker O, MacPhail C, Kahn K, Pettifor A . Does Partner Selection Mediate the Relationship Between School Attendance and HIV/Herpes Simplex Virus-2 Among Adolescent Girls and Young Women in South Africa: An Analysis of HIV Prevention Trials Network 068 Data. J Acquir Immune Defic Syndr. 2018, 79: 20-27
Stoner MCD, Edwards JK, Miller WC, Aiello AE, Halpern CT, Julien A, Selin A, Hughes JP, Wang J, Gomez-Olive XF, Wagner RW, MacPhail C, Kahn K, Pettifor A . Effect of Schooling on Age-Disparate Relationships and Number of Sexual Partners Among Young Women in Rural South Africa Enrolled in HPTN 068. J Acquir Immune Defic Syndr. 2017, 76: e107-e114
Stoner MCD, Edwards JK, Miller WC, Aiello AE, Halpern CT, Julien A, Selin A, Twine R, Hughes JP, Wang J, Laeyendecker O, Agyei Y, Tollman SM, Gomez-Olive FX, Wagner RW, MacPhail C, Kahn K, Pettifor A . The effect of school attendance and school drop out on incident HIV and HSV-2 among young women in rural South Africa enrolled in HPTN 068. AIDS. 2017, 31: 2127-2134
Stoner MCD, Nguyen N, Kilburn K, Gomez-Olive FX, Edwards JK, Selin A, Hughes JP, Agyei Y, MacPhail C, Kahn K, Pettifor A . Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa. AIDS. 2019, 33: 83-91
Stoner MCD, Rucinski KB, Edwards JK, Selin A, Hughes JP, Wang J, Agyei Y, Gomez-Olive FX, MacPhail C, Kahn K, Pettifor A . The Relationship Between School Dropout and Pregnancy Among Adolescent Girls and Young Women in South Africa: A HPTN 068 Analysis.
Straseski JA, Stolbach A, Clarke W . Opiate-positive immunoassay screen in a pediatric patient. Clin Chem. 2010, 56: 1220-3 PMCID: 2975969
Stringer E, Read JS, Hoffman I, Valentine M, Aboud S, Goldenberg RL . Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J. 2010, 100: 58-64 PMCID: 3090676
Stringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, Goldenberg RL, Stringer JS . Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr. 2004, 35: 60-6
Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA . Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2000, 24: 369-77
Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, Stout JP, Goldenberg RL, Kumwenda R, Vermund SH . Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 2003, 17: 1659-65
Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E . Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet. 2003, 362: 667
Stringer JS, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH . Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS. 2004, 18: 939-43
Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH . Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health. 2002, 92: 365-6
Sucato G, Celum CL, Dithmer D, Ashley RL, Wald A . Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescehts. Pediat Infect Dis. 2001, 20: 422-6
Sugarman J, Corneli A, Donnell D, Liu TY, Rose S, Celentano D, Jackson B, Aramrattana A, Wei L, Shao Y, Liping F, Baoling R, Dye B, Metzger D . Are there adverse consequences of quizzing during informed consent for HIV research?. J Med Ethics. 2011, 37: 693-7 PMCID: 3200567
Sugarman J, Grace WC . Ethics and the standards of prevention in HIV prevention trials - comment. AIDS. 2010, 24: 2298-9 PMID:20736687
Sugarman J, Mayer KH . Ethics and pre-exposure prophylaxis for HIV infection. J Acquir Immune Defic Syndr. 2013, 63: S135-9
Sugarman J, Rose SM, Metzger D . Ethical issues in HIV prevention research with people who inject drugs. Clin Trials. 2014, 11: 239-45
Sugarman J, Stalter R, Bokoch K, Liu T, and Donnell D, Donnell D . Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs. IRB: Ethics & Human Research. 2015, 37: 17-19
Susan H Eshleman, Estelle Piwowar-Manning, Mariya V. Sivay, Barbara Debevec, Stephanie Veater, Laura McKinstry, Linda Gail Bekker, Sharon Mannheimer, Robert M. Grant, Margaret A. Chesney, Thomas J. Coates, Beryl A. Koblin, Jessica M. Fogel, Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM . Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. J Clin Virol. 2018, 99-100: 67-70
Sweat M, Morin S, Celentano D, Mulawa M, Singh B, Mbwambo J, Kawichai S, Chingono A, Khumalo-Sakutukwa G, Gray G, Richter L, Kulich M, Sadowski A, Coates T . Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infectious Disease. 2011, 11: 525-32 PMCID: 3156626
T Gamble, B Branson, D Donnell, HI Hall, G King, B Cutler, S Hader, D Burns, J Leider, AF Wood, KG Volpp, WM El-Sadr . Design of the HPTN 065 (TLC-Plus) Study: A Study to Evaluate the Feasibility of an Enhanced Test, Link-to-Care, Plus Treat Approach for HIV Prevention in the United States. Clin Trials. 2017, 14: 322-332
Tabet S, Sanchez J, Lama J, Goicochea P, Campos P, Rouillon M, Cairo JL, Ueda L, Watts D, Celum C, Holmes K . HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS. 2002, 16: 1271-1277
Tabet SR, Callahan MM, Mauck CK, Gai F, Coletti AS, Profy AT, Moench TR, Soto-Torres LE, Poindexter AN, Frezieres RG, Walsh TL, Kelly CW, Richardson BA, van Damme L, Celum CL . Safety and Acceptability of Penile Application of 2 Candidate Topical Microbicides: BufferGel and PRO 2000 Gel: 3 Randomized Trials in Healthy Low-Risk Men and HIV-Positive Men. J Acquir Immune Defic Syndr. 2003, 33: 476-83
Tabet SR, Surawicz C, Horton S, Paradise M, Coletti AS, Gross M, Fleming TR, Buchbinder S, Haggitt RC, Levine H, Kelly CW, Celum CL . Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999, 26: 564-71
Taha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg R . A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006, 20: 1313-21 PMID: 16816561
Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Kumwenda NI, Miotti PG . Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998, 12: 197-203
Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, van Der Hoeven L, Liomba GN, Chiphangwi JD, Miotti PG . Morbidity among human immunodeficiency virus-1-infected and -uninfected African children. Pediatrics. 2000, 106: E77
Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG . Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998, 12: 1699-706
Taha TE, Hoover DR, Kumwenda NI, Fiscus SA, Kafulafula G, Nkhoma C, Chen S, Piwowar E, Broadhead RL, Jackson JB, Miotti PG . Late postnatal transmission of HIV-1 and associated factors. J Infect Dis. 2007, 196: 10-14 PMID: 17538877
Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, Mullis CE, Kumwenda JJ, Lingappa JR, Auvert B, Morrison CS, Mofensen LM, Taylor A, Fowler MG, Kumenda NI, Eshleman SH . Association of recent HIV infection and in-utero HIV-1 transmission. AIDS. 2011, 25: 1357-1364 PMCID: 3263827
Taha TE, Kumwenda N, Gibbons A, Hoover D, Lema V, Fiscus S, Mukiibi J, Liomba G, Broadhead R . Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants. AIDS. 2002, 16: 851-8
Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S, van der Hoven L, Markakis D, Liomba GN, Chiphangwi JD, Miotti PG . Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age. AIDS. 2000, 14: 453-9
Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL . Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting; a randomized controlled trial. JAMA. 2004, 292: 202-9
Taha TE, Kumwenda, Broadhead, Hoover, Graham, Hoeven, LV, D, Markakis, Liomba, GN, Chiphangwi, JD, Miotti, PG, Kumwenda NI, Broadhead RL, Hoover DR, Graham SM, Van Der Hoeven . Mortality after the first year of life among HIV infected and uninfected children. Ped Infect Dis J. 1999, 18: 689-94
Tedrow VA, Zelaya CE, Kennedy CE, Morin SF, Khumalo-Sakutukwa G, Sweat MD, Celentano DD . No "Magic Bullet": Exploring community mobilization strategies used in a multi-site community based randomized controlled trial: Project Accept (HPTN 043). AIDS Behav. 2012, 16: 1217-26
Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Young A, Donnell D, Fidler S, Hayes R, Hauck K, on behalf of the HPTN 071(PopART) Study Team . Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. Lancet Glob Health. 2017, 5: e1133-e1141
Thompson CG, Cohen MS, Kashuba AD . Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr. 2013, 63: S240-7
Tien PC, Chiu T, Latif AS, Ray S, Batra M, Contag CH, Zejenah L, Mbizvo M, Delwart EL, Mullins JI, Katzenstein DA . Primary subtype C HIV-1 infection in Harare, Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol. 1999, 20: 147-53
Tieu HV, Liu TY, Hussen S, Connor M, Wang L, Buchbinder S, Wilton L, Gorbach P, Mayer K, Griffith S, Kelly C, Elharrar V, Phillips G, Cummings V, Koblin B, Latkin C; HPTN 061 . Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 U.S. Cities. PLoS One. 2015, 10: e0134085
Tieu HV, Rolland M, Hammer SM, Sobieszczyk ME . Translational research insights from completed HIV vaccine efficacy trials. J Acquir Immune Defic Syndr. 2013, 63: S150-4
Tobian AA, Gaydos C, Gray RH, Kigozi G, Serwadda D, Quinn N, Grabowski MK, Musoke R, Ndyanabo A, Nalugoda F, Wawer MJ, Quinn TC . Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda. Sex Transm Infect. 2014, 90: 150-4
Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH . Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses. 2010, 26: 563-8 PMCID: 2875950
Towler WI, Church JD, Eshleman JR, Fowler MG, Guay LA, Jackson JB, Eshleman SH . Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). AIDS Res Hum Retroviruses. 2008, 24: 1209-13. PMCID:2562759
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH . Analysis of HIV diversity using a high-resolution melting assay. AIDS Res Hum Retroviruses. 2010, 26: 913-8 PMCID: 2920076
Trent M, Coleman JS, Hardick J, Perin J, Tabacco L, Huettner S, Ronda J, Felter-Wernsdorfer R, Gaydos CA . Clinical and Sexual
Risk Correlates of Mycoplasma Genitalium in Urban Pregnant and Non-Pregnant Young Women: Cross-Sectional Outcomes Using the Baseline Data from the Women's BioHealth Study
. Sex Transm Inf. 2018, 94: 411-413
Tsuyuki K, Shoptaw SJ, Ransome Y, Chau G, Rodriguez-Diaz CE, Friedman RK, Srithanaviboonchai K, Li S, Mimiaga MJ, Mayer KH, Safren SA . The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063). AIDS Behav. 2019, 23: 649-660
Valsamakis A . Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007, 20: 426-39
van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K . Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr. 2001, 26: 21-7
Van Der Pol B, Williams JA, Taylor SN, Cammarata CL, Rivers CA, Body BA, Nye M, Fuller D, Schwebke JR, Barnes M, Gaydos CA . Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol. 2014, 52: 885-9
van Rooyen H, McGrath N, Chirowodza A, Joseph P, Fiamma A, Gray G, Richter L, Coates T . Mobile VCT: Reaching Men and Young People in Urban and Rural South African Pilot Studies (NIMH Project Accept, HPTN 043). AIDS Behav. 2013, 17: 2946-53
Venkatesh KK, Madiba P, De Bruyn G, Lurie MN, Coates TJ, Gray GE . Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. JAIDS. 2011, 56: 151-65 PMCID: 3137901
Vermund SH, Hayes RJ . Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep. 2013, 10: 169-86
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, El-Sadr WM . Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis. 2010, 50: S149-55 PMCID: 2862583
Viljoen L, Ndubani R, Bond V, Seeley J, Reynolds L, Hoddinott G, on behalf of the HPTN 071 (PopART) Study Team . Community narratives about women and HIV risk in 21 high-burden communities in Zambia and South Africa. Int J Womens Health. 2017, 9: 861-870
Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, Martinez-Maza O, Bream JH . The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015, 29: 463-71
Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR 3rd, Cohen MS, Freedberg KA. . Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. NEJM. 2013, 369: 1715-25
Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, Gladden RG, Koelle DM . Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol. 2010, 48: 3496-503 PMCID: 2953087
Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W, George K, Richardson P, Zwerski S, Coovadia H, Fowler M; HPTN 046 Protocol Team, Fowler M, for the HPTN 046 Protocol Team . HIV Disease Progression in the First Year After Delivery Among African Women Followed in the HPTN 046 Clinical Trial. J Acquir Immune Defic Syndr. 2013, 64: 299-306